Drug Shortage Report for MAR-OLANZAPINE ODT
Report ID | 113128 |
Drug Identification Number | 02389088 |
Brand name | MAR-OLANZAPINE ODT |
Common or Proper name | OLANZAPINE ODT |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OLANZAPINE |
Strength(s) | 5MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL ORAL |
Packaging size | 30 Tablets |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2019-10-01 |
Estimated end date | Unknown |
Actual end date | 2019-10-01 |
Shortage status | Resolved |
Updated date | 2021-10-26 |
Company comments | Business reasons |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-10-26 | French | Compare |
v3 | 2021-10-26 | English | Compare |
v2 | 2020-04-24 | French | Compare |
v1 | 2020-04-24 | English | Compare |
Showing 1 to 4 of 4